Boardroom Alpha
10-Q primary document
BUR · Quarterly Report (Form 10-Q) · Filed August 6, 2026

Burford Capital Ltd10-Q exhibit

bur-20260630xex103.htm
Document
        Exhibit 10.3        
JOINDER
TO
AMENDED AND RESTATED AGREEMENT OF EXEMPTED LIMITED PARTNERSHIP
OF
BURFORD CAPITAL 2025 LP
May 21, 2026
    This Joinder (“Joinder”) to the Amended and Restated Agreement of Exempted Limited Partnership of Burford Capital 2025 LP, a Cayman Islands exempted limited partnership (the “Partnership”), dated as of December 31, 2025, as amended by Amendment Number 1 thereto, dated as of May 21, 2026 (the “Partnership Agreement”), by and among the General Partner and the Limited Partners thereof, is made and entered into as of the date set forth above by and between the General Partner and the undersigned (the “Additional Carried Interest Partners”). Capitalized terms used herein but not otherwise defined shall have the meanings set forth in the Partnership Agreement.
    WHEREAS, on the date hereof, the Additional Carried Interest Partners acquired Class B Carried Interest Percentages of the Partnership (collectively, the “Class B Carried Interest Percentages”), and the Additional Carried Interest Partners are required to become a party to the Partnership Agreement pursuant to Section 8.1 of the Partnership Agreement.
    NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Additional Carried Interest Partners hereby represent, warrant, acknowledge and agree with the General Partner and the Limited Partners as follows:
1.    The Additional Carried Interest Partners have been provided with a copy of the Partnership Agreement and hereby agree that upon execution of this Joinder, the Additional Carried Interest Partners shall each become a party to the Partnership Agreement as a Carried Interest Partner.
2.    The Additional Partners shall be bound by, and subject to, all of the covenants, terms and conditions of the Partnership Agreement.
3.    The signature page hereto shall be deemed to be a counterpart signature page to the Partnership Agreement.
[Remainder of Page Intentionally Left Blank; Signature Page Follows]



[Signature Page to Joinder to Burford Capital 2025 LP A&R Exempted Limited Partnership Agreement]
        
IN WITNESS WHEREOF, the parties hereto have executed this Joinder as of the date first above written.

GENERAL PARTNER:
ROWLAND INVESTMENTS LTD

By: /s/ Ben Gillooly                        
Name: Ben Gillooly
Title: Director
                    
ADDITIONAL CARRIED INTEREST PARTNERS:

    /s/ Jordan Licht    
Name: Jordan Licht
    /s/ Travis Lenkner    
Name: Travis Lenkner
/s/ Evan Meyerson    
Name: Evan Meyerson

/s/ Carrie Tendler    
Name: Carrie Tendler
                    


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer